Effects of Casomorphin or Casein Peptides on the Blood Glucose Level in the Diabetic Rats

YIN Hong,LIU Lei,JIANG Xiao-fang,SUN Bing,ZHANG Yuan-shu
2011-01-01
Abstract:Fifty male SD rats were divided into two groups:a nondiabetic control(n=8)and a diabetic group(n=42).Sreptozocin(STZ)was administered intraperitoneally(i.p.)at a single dose of 60 mg·kg-1 to diabetic group.The control rats were only injected with the citrate buffer.Collecting serum at 24 h and 72 h after STZ treatment,the development of diabetes was confirmed by measuring blood glucose levels.The rats with blood glucose level 11.1 mmol·L-1 or higher were considered to be diabetic and were used in the experiment.The diabetic rats(n=32)were randomly divided into four groups:positive control rats,β-casomorphin-7(β-CM7)treated diabetic rats,casein peptides treated diabetic rats,casein treated diabetic rats.Every 3 days of experimentation,blood samples were collected for biochemical estimations.On the last day of experiment,the animals were deprived of food overnight and sacrificed by cervical dislocation.Blood was collected in sterilized tubes with the anticoagulant.Then the liver,heart and leg muscle were removed.Observed were the changes of the blood glucose level and other important indicators which are associated with the blood glucose.The results showed after 15 days oral administration of β-CM7 or casein peptides,the elevated blood glucose level was reduced.The oral administration of β-CM7 or casein peptides to diabetic rats showed an increase in the level of plasma insulin,and the elevated plasma glucagon level was markedly reduced by the oral administration of β-CM7 or casein peptides compared with positive control rats.The blood glucose,plasma insulin,glucagon and glycogen level of casein peptides treated diabetic rats is as the same as those of the positive control rats.Thus,the results of the present study suggest that β-CM7 or casein peptides can decrease the blood glucose by elevating insulin secretion or promoting glycogen synthesis.Hypoglycemic effect of casein itself can not.
What problem does this paper attempt to address?